Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D004317 |
Doxorubicin |
KAZN protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D016685 |
Mitomycin |
KAZN protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of KAZN mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of KAZN mRNA | affects cotreatment|decreases expression | 19059307
|
D014501 |
Uranium |
Uranium affects the expression of KAZN mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of KAZN mRNA | affects expression | 15672453
|
D014747 |
Vinblastine |
KAZN protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.62 | 17418594 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
12.58 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
12.58 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.59 | 15800139 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.83 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.00 | 18628466 16595493 16096432 16115903 18695136 15634643 19526202 16322301 16264153 15994142 15136595 17426702 15939500 15567936 15668708 18382427 16826403 17983394 16935488 17369602 15692762 11325840 15993339 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.00 | 15758505 17242785 17893378 17261762 15572757 15775269 17595753 17049068 17952589 17440819 16837676 16912660 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.00 | 19059307 20135344 18425577 19189210 17440819 19084267 20859285 16202921 19288272 15565566 19289846 17893378 19410462 15668708 16873071 19142967 19103187 18351453 16273361 18629630 19487384 19189212 21138602 17242785 19200415 19115204 17261762 19221464 21152245 18855134 19244106 19011961 20390343 18815881 17049068 19155303 18997820 11161223 20005174 20544844 18984771 18821012 16818667 20065188 19066611 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.26 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.26 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.33 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
7.33 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.40 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
10.40 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 17382496 16109756 15792986 16269455 15811867 17308081 16952015 15505089 16278810 16364871 17974986 17329180 16612575 18627295 17928571 17351982 17007740 15476868 17924179 16651473 16242529 17131338 16455267 16731534 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.63 | 15775269 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.98 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.98 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
2.98 | 18802399 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.41 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.87 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.87 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.50 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.87 | 18602426 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.61 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.36 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.36 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
8.13 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
8.13 | 16202921 19155303 20544844 17893378 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.94 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.94 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
12.80 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
12.80 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
8.46 | 18674790 16330681 17875725 16707910 16495754 16144979 16244372 17888722 16879835 12587719 18006777 16244371 14766674 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
8.46 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.50 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.63 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
8.63 | 18501091 18180244 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.95 | 17577099 15787275 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.48 | 19457130 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.27 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.80 | 16973256 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.68 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.68 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
5.26 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
5.26 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.17 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.65 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.65 | 18625569 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.70 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.70 | 19196722 11731420 19196723 14580682 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.49 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.49 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
5.49 | 18332650 15577320 15577323 18176117 16432458 12374674 16248763 17761969 16809738 18505091 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
6.00 | 15863610 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.63 | 16497877 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.04 | 15857846 19429709 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
6.00 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.18 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.18 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19189210 19196722 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 15640375 16889571 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.39 | 15555623 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.87 | 17378895 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.55 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.53 | 17823083 17893378 15579764 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
3.53 | 15113037 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.60 | 15897917 15749863 18437689 16868541 16729912 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.60 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.60 | 15067354 |
MESH:D011693 |
Purpura |
|
Raloxifene |
6.00 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 17203757 16767912 18313854 15625365 15675481 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.06 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.74 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.04 | 16837676 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.58 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.65 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.97 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.97 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.97 | 16712894 8653321 17572228 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.40 | 15577323 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.65 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17678736 17638931 17334414 16364871 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
6.00 | 16343187 |